These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30835325)

  • 1. Relationship between the CHA2DS2-VASc score and atrial fibrillation in patients hospitalised due to heart failure.
    Kuczaj A; Nowalany-Kozielska E; Skrzypek M; Opolski G; Ociessa A; Jankowska E; Ponikowski P; Wożakowska-Kapłon B; Mirek-Brynarska E; Drożdż J
    Kardiol Pol; 2019; 77(3):380-385. PubMed ID: 30835325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
    Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
    JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
    Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
    Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CHA
    Marzouka GR; Rivner H; Mehta V; Lopez J; Vaz I; Tang F; Ishwaran H; Goldberger JJ
    Am J Cardiol; 2021 Sep; 155():72-77. PubMed ID: 34274114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-stroke CHADS2 and CHA2DS2-VASc scores are useful in stratifying three-month outcomes in patients with and without atrial fibrillation.
    Tu HT; Campbell BC; Meretoja A; Churilov L; Lees KR; Donnan GA; Davis SM
    Cerebrovasc Dis; 2013; 36(4):273-80. PubMed ID: 24135809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting stroke and death in patients with heart failure using CHA
    Son MK; Lim NK; Park HY
    BMC Cardiovasc Disord; 2019 Aug; 19(1):193. PubMed ID: 31395009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Echocardiographic parameters versus CHA2DS2-VASc score in prediction of overall cardiac events, heart failure, and stroke in non-valvular atrial fibrillation.
    Yang LT; Tsai WC; Su HM
    Cardiol J; 2018; 25(1):60-71. PubMed ID: 28714523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of CHA2DS2-VASc scores regarding the risk of stroke and all-cause mortality in patients with atrial fibrillation (CONSORT compliant).
    Gažová A; Leddy JJ; Rexová M; Hlivák P; Hatala R; Kyselovič J
    Medicine (Baltimore); 2019 Aug; 98(31):e16560. PubMed ID: 31374021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHA
    Yi JE; Lee YS; Choi EK; Cha MJ; Kim TH; Park JK; Lee JM; Kang KW; Shim J; Uhm JS; Kim J; Kim C; Kim JB; Park HW; Joung B; Park J
    Sci Rep; 2018 Dec; 8(1):18039. PubMed ID: 30575764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CHA2DS2-VASc score is directly associated with the risk of pulmonary embolism in patients with atrial fibrillation.
    Saliba W; Rennert G
    Am J Med; 2014 Jan; 127(1):45-52. PubMed ID: 24384101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stroke Risk as a Function of Atrial Fibrillation Duration and CHA
    Kaplan RM; Koehler J; Ziegler PD; Sarkar S; Zweibel S; Passman RS
    Circulation; 2019 Nov; 140(20):1639-1646. PubMed ID: 31564126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CHA
    Sonaglioni A; Lonati C; Rigamonti E; Viganò M; Nicolosi GL; Proietti M; Lombardo M; Harari S
    Aging Clin Exp Res; 2022 Jul; 34(7):1707-1720. PubMed ID: 35294768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation.
    Letsas KP; Efremidis M; Giannopoulos G; Deftereos S; Lioni L; Korantzopoulos P; Vlachos K; Xydonas S; Kossyvakis C; Sideris A
    Europace; 2014 Feb; 16(2):202-7. PubMed ID: 23813452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy.
    Paoletti Perini A; Bartolini S; Pieragnoli P; Ricciardi G; Perrotta L; Valleggi A; Vergaro G; Michelotti F; Boggian G; Sassone B; Mascioli G; Emdin M; Padeletti L
    Europace; 2014 Jan; 16(1):71-80. PubMed ID: 23828875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation: Utility of CHADS
    Lahewala S; Arora S; Patel P; Kumar V; Patel N; Tripathi B; Patel N; Kallur KR; Shah H; Syed A; Gidwani U; Viles-Gonzalez JF; Deshmukh A
    Int J Cardiol; 2017 Oct; 245():162-167. PubMed ID: 28874288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHA
    Parsons C; Patel SI; Cha S; Shen WK; Desai S; Chamberlain AM; Luis SA; Aguilar MI; Demaerschalk BM; Mookadam F; Shamoun F
    Mayo Clin Proc; 2017 Mar; 92(3):360-369. PubMed ID: 28259228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHA2DS2-VASc score and fibrinogen concentration in patients with atrial fibrillation.
    Semczuk-Kaczmarek K; Płatek AE; Ryś A; Adamowicz J; Legosz P; Kotkowski M; Dudzik-Płocica A; Gorko D; Szymański FM; Filipiak KJ
    Adv Clin Exp Med; 2019 Nov; 28(11):1451-1457. PubMed ID: 31596555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHA
    Kim TH; Yang PS; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
    Stroke; 2017 Jun; 48(6):1524-1530. PubMed ID: 28455320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Stratification for Ischemic Cerebrovascular Events and Mortality among Intracerebral Hemorrhage Patients with and without Atrial Fibrillation: A Nationwide Cohort Study.
    Nielsen PB; Overvad TF; Andersen SD; Larsen TB; Skjøth F; Søgaard M; Lip GYH
    Cerebrovasc Dis; 2019; 48(3-6):236-243. PubMed ID: 31846970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.